Pharmacokinetics of famotidine in goats after intravenous administration.
abomasal ulceration
gastric
gastroprotectant
histamine
ruminant
Journal
Journal of veterinary pharmacology and therapeutics
ISSN: 1365-2885
Titre abrégé: J Vet Pharmacol Ther
Pays: England
ID NLM: 7910920
Informations de publication
Date de publication:
08 May 2024
08 May 2024
Historique:
revised:
04
04
2024
received:
31
12
2023
accepted:
11
04
2024
medline:
9
5
2024
pubmed:
9
5
2024
entrez:
9
5
2024
Statut:
aheadofprint
Résumé
There is currently limited pharmacokinetic data for the use of famotidine in goats for treatment and prevention of abomasal ulceration. The objective of this study was to determine the pharmacokinetic parameters after a single intravenous administration of famotidine (0.6 mg/kg). Famotidine was administered to six healthy goats and plasma samples were collected over a 24-h period. The famotidine concentration was measured using reverse phase high-performance liquid chromatography (HPLC). Non-compartmental analysis was then used to determine the pharmacokinetic parameters. The maximum plasma concentration was estimated at 5476.68 ± 1530.51 ng/mL and elimination half-life was estimated at 18.455 ± 13.26 min. The mean residence time was determined to be 19.85 ± 12.14 min with the apparent volume of distribution being estimated at 321.924 ± 221.667. The area under the curve was determined to be 54230.08 ± 24947.6 min*ng/mL. Total exposure and elimination half-life were less than what has been reported in cattle and horses. Future research evaluating the pharmacokinetics of subcutaneous administration and looking at the pharmacodynamics of famotidine in goats is needed to determine the effectiveness of famotidine on raising pH levels of the abomasum.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : University of Tennessee's Chancellor's Honors College
Organisme : University of Tennessee, College of Veterinary Medicine
Informations de copyright
© 2024 John Wiley & Sons Ltd.
Références
Al‐Omar, M. A., & Al‐Mohizea, A. M. (2009). Chapter 3 famotidine. Profiles of Drug Substances, Excipients and Related Methodology, 34, 115–151. https://doi.org/10.1016/s1871‐5125(09)34003‐0
Balcomb, C. C., Heller, M. C., Chigerwe, M., Knych, H. K., & Meyer, A. M. (2018). Pharmacokinetics and efficacy of intravenous famotidine in adult cattle. Journal of Veterinary Internal Medicine, 32(3), 1283–1289. https://doi.org/10.1111/jvim.15080
Bon, C., Toutain, P. L., Concordet, D., Gehring, R., Martin‐Jimenez, T., Smith, J., Pelligand, L., Martinez, M., Whittem, T., Riviere, J. E., & Mochel, J. P. (2018). Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed‐effects to characterize and quantify variability in drug pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics, 41(2), 171–183. https://doi.org/10.1111/jvp.12473
Duran, S. H. (2003). Pharmacokinetics of histamine type II antagonists in large and small domestic animals. Auburn University.
Echizen, H., & Ishizaki, T. (1991). Clinical pharmacokinetics of famotidine. Clinical Pharmacokinetics, 21(3), 178–194. https://doi.org/10.2165/00003088‐199121030‐00003
Fladung, R., Smith, J. S., Hines, M. T., Soto‐Gonzalez, W. M., Fayne, B., Rahn, R. R., Escher, O. G., Harvill, L., Bergman, J., Cox, S., Kreuder, A. J., & Garcia, J. D. (2022). Pharmacokinetics of esomeprazole in goats (Capra aegagrus hircus) after intravenous and subcutaneous administration. Frontiers in Veterinary Science, 9, 968973.
Hess, S., & Decker, M. (2017). Comparison of the single‐syringe push‐pull technique with the discard technique for obtaining blood samples from pediatric central venous access devices. Journal of Pediatric Oncology Nursing, 34(6), 381–386.
Howden, C. W., & Tytgat, G. N. (1996). The tolerability and safety profile of famotidine. Clinical Therapeutics, 18(1), 36–54.
Humphries, T. J. (1987). Famotidine: A notable lack of drug interactions. Scandinavian Journal of Gastroenterology. Supplement, 134, 55–60. https://doi.org/10.3109/00365528709090142
Hund, A., & Wittek, T. (2018). Abomasal and third compartment ulcers in ruminants and south American camelids. The Veterinary Clinics of North America. Food Animal Practice, 34(1), 35–54. https://doi.org/10.1016/j.cvfa.2017.10.003
Langtry, H. D., Grant, S. M., & Goa, K. L. (1989). Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases. Drugs, 38(4), 551–590. https://doi.org/10.2165/00003495‐198938040‐00005
Marks, S. L., Kook, P. H., Papich, M. G., Tolbert, M. K., & Willard, M. D. (2018). ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats. Journal of Veterinary Internal Medicine, 32(6), 1823–1840. https://doi.org/10.1111/jvim.15337
Olivarez, J. D., Kreuder, A. J., Tatarniuk, D. M., Wulf, L. W., Dembek, K. A., Mochel, J. P., & Smith, J. S. (2020). Pharmacokinetics and tissue levels of pantoprazole in neonatal calves after intravenous administration. Frontiers in Veterinary Science, 7(846), 580735. https://doi.org/10.3389/fvets.2020.580735
Olivarez, J. D., Mulon, P. Y., Ebner, L. S., Cremerius, H., Cantrell, C., Rahn, R., Soto‐Gonzalez, W., Bergman, J., Cox, S., Mochel, J. P., Kreuder, A. J., & Smith, J. S. (2022). Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves. Frontiers in Veterinary Science, 9, 1101461. https://doi.org/10.3389/fvets.2022.1101461
Smith, J. S., Gebert, J., Bennett, K., Ebner, L. S., Flynn, R., Mulon, P.‐Y., Harvill, L., Escher, O. G., Kreuder, A. J., Bergman, J., & Cox, S. (2023). The pharmacokinetics and pharmacodynamics of esomeprazole in sheep after intravenous dosing. Frontiers in Veterinary Science, 10, 1172023. https://doi.org/10.3389/fvets.2023.1172023
Smith, J. S., Kosusnik, A. R., & Mochel, J. P. (2020). A retrospective clinical investigation of the safety and adverse effects of pantoprazole in hospitalized ruminants. Frontiers in Veterinary Science, 7, 97.
Smith, J. S., Mochel, J. P., Soto‐Gonzalez, W. M., Rahn, R. R., Fayne, B. N., Escher, O. G., Geletka, A. M., Harvill, L. E., Bergman, J. B., & Cox, S. (2021). Pharmacokinetics of pantoprazole and pantoprazole sulfone in goats after intravenous administration: A preliminary report. Frontiers in Veterinary Science, 8(1081), 744813. https://doi.org/10.3389/fvets.2021.744813
Taha, A. S., Hudson, N., Hawkey, C. J., Swannell, A. J., Trye, P. N., Cottrell, J., Mann, S. G., Simon, T. J., Sturrock, R. D., & Russell, R. I. (1996). Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. The New England Journal of Medicine, 334(22), 1435–1439. https://doi.org/10.1056/nejm199605303342204
Tolbert, M. K., Graham, A., Odunayo, A., Price, J., Steiner, J. M., Newkirk, K., & Hecht, S. (2017). Repeated famotidine administration results in a diminished effect on Intragastric pH in dogs. Journal of Veterinary Internal Medicine, 31(1), 117–123. https://doi.org/10.1111/jvim.14615